Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy

about

Evaluating outcomes of mother-infant pairs using dolutegravir for HIV treatment during pregnancy

Item

http://www.wikidata.org/entity/Q58767934

description

article

@en

im September 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@en

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@nl

type

Item

label

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@en

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@nl

prefLabel

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@en

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@nl

P1476

Evaluating outcomes of mother- ...... HIV treatment during pregnancy

@en

P2093

Anandi Sheth

http://www.w3.org/2001/XMLSchema#string

Clara Grayhack

http://www.w3.org/2001/XMLSchema#string

Erika Aaron

http://www.w3.org/2001/XMLSchema#string

Florence Momplaisir

http://www.w3.org/2001/XMLSchema#string

Gregg Alleyne

http://www.w3.org/2001/XMLSchema#string

Hervette Nkwihoreze

http://www.w3.org/2001/XMLSchema#string

Jennifer Davis

http://www.w3.org/2001/XMLSchema#string

Kedesha Sibliss

http://www.w3.org/2001/XMLSchema#string

Martina Badell

http://www.w3.org/2001/XMLSchema#string

Olivia Kirby

http://www.w3.org/2001/XMLSchema#string

P2860

Time of HIV Diagnosis and Engagement in Prenatal Care Impact Virologic Outcomes of Pregnant Women with HIV

Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.

Factors associated with lack of viral suppression at delivery among highly active antiretroviral therapy-naive women with HIV: a cohort study

Postpartum Loss to HIV Care and HIV Viral Suppression among Previously Diagnosed HIV-Infected Women with a Live Birth in New York State.

Integrase inhibitors in late pregnancy and rapid HIV viral load reduction.

Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.

Pharmacokinetics and Placental Transfer of Elvitegravir, Dolutegravir, and Other Antiretrovirals during Pregnancy.

A Single-Center Retrospective Cohort Analysis of Maternal and Infant Outcomes in HIV-Infected Mothers Treated with Integrase Inhibitors During Pregnancy.

Successful prevention of HIV mother-to-child transmission with dolutegravir-based combination antiretroviral therapy in a vertically infected pregnant woman with multiclass highly drug-resistant HIV-1.

Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIV.

P304

2017-2021

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000001931

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Aadia Rana

P577

2018-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29944472

http://www.w3.org/2001/XMLSchema#string

P921

immunology

infectious disease

P932

6125741

http://www.w3.org/2001/XMLSchema#string